NCT03322124View on ClinicalTrials.gov

Study to Assess the Inhibition of Plaque Formation in Subjects With a Gingival Index ≤1.5

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 22, 2018

Primary Completion Date

December 14, 2018

Study Completion Date

December 14, 2018

Conditions
Inhibition of Plaque Formation (by Gingivitis-Index ≤1.5)
Interventions
DRUG

Octenidinedihydrochlorid

Mouth rinsing of the oral cavity with Octenidinehydrochlorid vs.Placebo over a period of 5 days

OTHER

Placebo

Mouth rinsing of the oral cavity with Octenidinehydrochlorid vs.Placebo over a period of 5 days

Trial Locations (3)

60596

Poliklinik für Parodontologie der Johann Wolfgang Goethe Universität Frankfurt am Main, Frankfurt am Main

01307

Poliklinik für Parodontologie der Med. Fakultät C. G. Carus der TU Dresden, Dresden

04103

Poliklinik für Zahnerhaltung und Parodontologie am Universitätsklinikum Leipzig, Leipzig

All Listed Sponsors
lead

Schülke & Mayr GmbH

INDUSTRY

NCT03322124 - Study to Assess the Inhibition of Plaque Formation in Subjects With a Gingival Index ≤1.5 | Biotech Hunter | Biotech Hunter